Theremia
French tech company | Builders Republic
About
Healthtech company building AI models that personalize drug dosing — recommending the right formulation, dose and dosing frequency for individual patient profiles to improve efficacy and limit side effects, focused first on neurological and central-nervous-system treatments for pharma partners.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Seed
- Founded
- 2024
- City
- BOULOGNE-BILLANCOURT
- Region
- IDF
- Tracked rounds
- 1
- Amount raised
- 3.0 M€ raised since 2020
Funding rounds
- Seed — 2024
Investors
- Entrepreneur First
- Eurazeo
- Salica Investments
- Tiny Supercomputer Investment Company (TSIC) / Tiny VC